- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03013699
Diet Intervention, Head and Neck Cancer, Feasibility
Improving Dietary Patterns in Head and Neck Cancer Survivors to Optimize Disease Outcomes and Supportive Care: A Pilot/Feasibility Intervention Study
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
Patients will be eligible to participate if they are 1) diagnosed with Stage I - IV oral, hypopharyngeal, nasopharyngeal, oropharyngeal, or laryngeal cancer; 2) age 19+; 3) at least 6 months - 2 years post-treatment; 4) able to consume foods orally; 5) no evidence of disease; 6) English-speaking
Exclusion Criteria:
Patients will not be eligible to participate if they have 1) dementia or organic brain syndrome; 2) severe emotional distress; 3) active schizophrenia; 3) another diagnosis of cancer in the past five years (not including skin or cervical cancer in situ)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Comparatore attivo: Usual Dietary Care
Participants receive standard educational materials that focus on healthy eating for cancer survivors and the opportunity to briefly discuss nutrition-related concerns with the Registered Dietitian weekly.
|
Participants receive standard educational materials that focus on healthy eating for cancer survivors and the opportunity to briefly discuss nutrition-related concerns with the Registered Dietitian weekly.
|
Sperimentale: Cruciferous and Dark Leafy Green Intervention
Participants receive individual dietary counseling from a Registered Dietitian who will focus on increasing intake of cruciferous and green leafy vegetables while addressing any disease- and treatment-related eating difficulties experienced by the participant.
|
Participants receive individual dietary counseling from a Registered Dietitian who will focus on increasing intake of cruciferous and green leafy vegetables while addressing any disease- and treatment-related eating difficulties experienced by the participant.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Number of patients excluded or not agreeing to participate
Lasso di tempo: Baseline
|
Feasibility measure
|
Baseline
|
Adherence to study protocol activities (research records and diet intake self-report)
Lasso di tempo: Throughout 12 week study period
|
Feasibility measure (e.g., percent of assessments completed, percent of counseling phone calls completed, servings of cruciferous vegetables eaten, etc.)
|
Throughout 12 week study period
|
Attrition rates
Lasso di tempo: Throughout 12 week study period
|
Feasibility measure
|
Throughout 12 week study period
|
Adverse events with reporting according to institutional review board policy
Lasso di tempo: Throughout 12 week study period
|
Throughout 12 week study period
|
|
Questionnaire
Lasso di tempo: At conclusion of 12 week study period
|
Participant satisfaction
|
At conclusion of 12 week study period
|
Questionnaire
Lasso di tempo: At conclusion of 12 week study period
|
Intervention preferences
|
At conclusion of 12 week study period
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
DNA methylation
Lasso di tempo: At beginning and end of 12 week study period
|
At beginning and end of 12 week study period
|
|
Serum cytokines
Lasso di tempo: At beginning and end of 12 week study period
|
At beginning and end of 12 week study period
|
|
Quality of life (assessed using the Functional Assessment of Cancer Therapy Head and Neck index)
Lasso di tempo: At beginning and end of 12 week study period
|
At beginning and end of 12 week study period
|
|
Total energy and nutrient intakes
Lasso di tempo: At beginning and end of 12 week study period
|
At beginning and end of 12 week study period
|
|
Covariates
Lasso di tempo: At beginning of 12 week study period
|
A questionnaire will collect a set of covariates used in the analyses (i.e., these do not represent individual outcomes; this is a group of covariates used in the data analyses).
This group includes demographic characteristics (age, sex, race, ethnicity, education, income); lifestyle behaviors (tobacco use, alcohol consumption, exercise); medical history; cancer-specific clinical variables (tumor site, cancer stage, treatment modality); anthropometrics (height and weight)
|
At beginning of 12 week study period
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Laura Q. Rogers, MD, University of Alabama at Birmingham
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- X140813004
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Cancro testa e collo
-
Novartis PharmaceuticalsReclutamentoEGFR mutante avanzato Non SmallSellLung Cancer (NSCLC), KRAS G12-mutant NSCLC, Esophageal SquamousCell Cancer (SCC), Head/Neck SCC, MelanomaOlanda, Corea, Repubblica di, Spagna, Taiwan, Giappone, Italia, Stati Uniti, Singapore, Canada
Prove cliniche su Usual Dietary Care
-
Aarogyam UKNMP Medical Research Institute; Croydon Ayurveda Centre; Active Naturals Limited; AVP Research FoundationAttivo, non reclutanteDisturbo psichiatricoIndia
-
Massachusetts General HospitalNational Institutes of Health (NIH); Samaritans of BostonNon ancora reclutamentoIdeazione suicida | Suicidio, tentato | Suicidio
-
French Red CrossInstitut National de la Santé Et de la Recherche Médicale, France; University... e altri collaboratoriReclutamentoAttività fisica | Crescita | Dieta | Comportamento sedentario | InfanteFrancia
-
Vrije Universiteit BrusselUniversitaire Ziekenhuizen KU Leuven; KU LeuvenReclutamentoArtrosi, ginocchio | InsonniaBelgio
-
Medical College of WisconsinReclutamentoDiabete di tipo 2Stati Uniti
-
Henry M. Jackson Foundation for the Advancement...National Institute of Mental Health (NIMH); United States Department of DefenseCompletatoDisturbo post-traumatico da stress (PTSD)Stati Uniti
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalAttivo, non reclutanteSmettere di fumare | Cancro ai polmoniStati Uniti
-
University of Texas at AustinSconosciutoSclerosi multiplaStati Uniti
-
University of PittsburghNational Institute of Nursing Research (NINR)CompletatoTumori cerebrali maligni primariStati Uniti
-
Rhode Island HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletatoCyber bullismoStati Uniti